Literature DB >> 23933924

Liver transplantation treating the patient with hepatic failure associated with sorafenib treatment: report of a case.

Jianhua Rao, Min Feng, Xiaofeng Qian, Guoqiang Li, Xuehao Wang, Feng Zhang, Ling Lu.   

Abstract

For the first time ever, sorafenib-induced hepatic failure has been cured by liver transplantation. A 54-year-old man, he underwent surgery for papillary carcinoma of thyroid gland two years ago. After two years follow up, a left neck lymph node metastasis was found and he was treated with sorafenib (800 mg/day). However, two days later, hepatic failure associated with sorafenib developed and he was treated with liver transplantation. The donor was a victim of road accident. Even though hepatic failure associated with sorafenib treatment is rare, the possible development of hepatic failure in patients undergoing sorafenib treatment must be kept in mind.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23933924     DOI: 10.5754/hge13185

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

Review 1.  Hepatitis C virus reactivation in cancer patients in the era of targeted therapies.

Authors:  Ozan Yazici; Mehmet Ali Nahit Sendur; Sercan Aksoy
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

Review 2.  Molecular targeted therapy-related life-threatening toxicity in patients with malignancies. A systematic review of published cases.

Authors:  Sandra Assoun; Virginie Lemiale; Elie Azoulay
Journal:  Intensive Care Med       Date:  2019-05-29       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.